Inhibition of Ebola virus glycoprotein-mediated cytotoxicity by targeting its transmembrane domain and cholesterol.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 26158910.
- Also identified by DOI 10.1038/ncomms8688.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The high pathogenicity of the Ebola virus reflects multiple concurrent processes on infection. Among other important determinants, Ebola fusogenic glycoprotein (GP) has been associated with the detachment of infected cells and eventually leads to vascular leakage and haemorrhagic fever. Here we report that the membrane-anchored GP is sufficient to induce the detachment of adherent cells. The results show that the detachment induced through either full-length GP1,2 or the subunit GP2 depends on cholesterol and the structure of the transmembrane domain. These data reveal a novel molecular mechanism in which GP regulates Ebola virus assembly and suggest that cholesterol-reducing agents could be useful as therapeutics to counteract GP-mediated cell detachment.
Medical subject headings
- Anticholesteremic Agents
- Cell Adhesion
- Cell Membrane
- Cholesterol
- Cytochalasin B
- Ebolavirus
- Simvastatin
- Viral Fusion Proteins
- beta-Cyclodextrins